郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 6: Opioid receptor binding properties of cyclic variants of 8-carboxamidocyclazocine.

期刊：Bioorganic & medicinal chemistry发表年份：2008作者：Mark P Wentland; Xufeng Sun; Dana J Cohen; Jean M Bidlack
阅读更多 →

药效评价Synthesis of bivalent beta2-adrenergic and adenosine A1 receptor ligands.

期刊：Journal of medicinal chemistry发表年份：2008作者：Peter Karellas; Michael McNaughton; Stephen P Baker; Peter J Scammells
阅读更多 →

药效评价Immunosuppressant calcineurin inhibitors phase shift circadian rhythms and inhibit circadian responses to light.

期刊：Pharmacology, biochemistry, and behavior发表年份：2008作者：Marcelo E Katz; Sergio H Simonetta; Martin R Ralph; Diego A Golombek
阅读更多 →

药效评价High-throughput screening for reactive oxygen species scavengers targeting mitochondria.

期刊：Methods and findings in experimental and clinical pharmacology发表年份：2008作者：Xiu-Ping Chen; Guan-Hua Du
阅读更多 →